Featured News
Leading firm eyes collaboration with Brunei in cancer prevention
Author : Borneo Bulletin- James Kon
Published: April 4, 2012
IBA, the leading global Belgium firm in developing cutting-edge technologies, pharmaceutical and tailor-made solutions for healthcare that focus on cancer diagnosis and therapy, is looking at collaborating with Brunei to bring in the latest technology and application for early detection and prevention of cancer.
IBA's Mr Peter Leitner VP Cyclotron Solutions APAC during a press conference said, "We are promoting collaboration and start up of molecular imaging as well as radiation therapy with proton particulars. It is a very strong, growing application for early cancer detection, neuro as well as cardiac diseases."
The latest technology, he explained, "Offers more efficient treatment through guidance by molecular imaging and treatment through proton therapy installation which is a very low invasive but high efficient treatment for various cancers."
"We are specific player in a niche and leading in the market with six out of 10 therapies coming from IBA. We are looking forward to future collaboration with Brunei to bring in the efficient and powerful technology to Brunei," he said.
"We held a meeting with the Ministry of Health today and it was very fruitful. It's a first step to get to know officials here. We are looking to come here again to meet the various medical communities to evaluate how such project can be done in Brunei."
IBA's technology "will be good for the locals and also for attracting medical tourism in Brunei."
He also noted the National Cancer Centre is in the process of building its multi-million state-of-the-art building and there might be potential for collaboration in the area.
Meanwhile, Alain Arthoens, the Managing Partner of Vesalius Biocapital, Belgium, a company that invests in innovations in medical breakthroughs, is looking at a win-win situation by providing the country with access to the newest technology and sharing expertise on registering products in Brunei.
He explained, " I created the firm Vesalius. We invest in innovative companies in health and biotech technology… companies that will develop medicine for treatment like cell therapy, and breakthrough in technology. We have received some 700 proposals of investment from European companies and invested in 12 companies."
Other News
Contact us
